Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus

Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is associated with an increased incidence of acute and chronic cardiovascular disease as compared to the general population. This study uses a comprehensive metabolomic screen of baseline sera from lupus patients to identify metabolites that predict future carotid...

Full description

Bibliographic Details
Main Authors: Sahar Baig, Kamala Vanarsa, Huihua Ding, Anto Sam Crosslee Louis Sam Titus, Maureen McMahon, Chandra Mohan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atherosclerosis
biomarkers
blood
lupus
metabolites
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.861724/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.861724/full

Similar Items